Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, focusing on innovative novel cancer immunotherapeutics
Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, focusing on innovative novel cancer immunotherapeutics. With its Immune Repertoire Capture™ (IRC™) technology, Atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes.